首页> 外国专利> USE OF LEVOSIMENDAN OR SALTS THEREOF FOR PRODUCING A DRUG FOR TREATING ALZHEIMER'S DISEASE AND RELATED DISORDERS OR FOR PROTECTING ENDOTHELIAL AND/OR GANGLIAN CELLS AGAINST Aβ TOXICITY, AND METHOD OF TREATING SAID DISEASES

USE OF LEVOSIMENDAN OR SALTS THEREOF FOR PRODUCING A DRUG FOR TREATING ALZHEIMER'S DISEASE AND RELATED DISORDERS OR FOR PROTECTING ENDOTHELIAL AND/OR GANGLIAN CELLS AGAINST Aβ TOXICITY, AND METHOD OF TREATING SAID DISEASES

机译:左西孟旦或其盐用于生产药物以治疗老年痴呆症和相关疾病或保护抗Aβ毒性的内皮细胞和/或神经胶质细胞的方法以及治疗上述疾病的方法

摘要

The present invention relates to the use of levosimendan or salts thereof for producing a drug for treating Alzheimer's disease and related disorders or for protecting endothelial and/or ganglion cells against Aβ toxicity, and also to a method of treating said diseases. In particular, the invention concerns the use of levosimendan or salts thereof which, alone or in combination(s), can effectively modulate synapse function and/or angiogenesis and/or cell stress response.
机译:本发明涉及左西孟旦或其盐在生产用于治疗阿尔茨海默氏病和相关疾病或保护内皮和/或神经节细胞免受Aβ毒性的药物中的用途,并且还涉及治疗所述疾病的方法。特别地,本发明涉及左西孟旦或其盐的用途,其单独或组合使用可有效地调节突触功能和/或血管生成和/或细胞应激反应。

著录项

  • 公开/公告号EA024465B1

    专利类型

  • 公开/公告日2016-09-30

    原文格式PDF

  • 申请/专利权人 PHARNEXT;

    申请/专利号EA20120000686

  • 申请日2010-10-29

  • 分类号A61K31/137;A61K31/155;A61K31/167;A61K31/185;A61K31/195;A61K31/343;A61K31/423;A61K31/4985;A61P25/28;

  • 国家 EA

  • 入库时间 2022-08-21 14:26:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号